|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.999
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.962
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.962
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.936
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.913
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.902
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.894
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.888
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.881
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.872
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.834
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.829
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.807
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.789
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.787
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.786
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.785
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.764
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.728
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.714
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.707
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.706
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.702
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.700
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.693
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.644
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.639
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.630
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.624
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.598
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.595
|
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.591
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.559
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.541
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.532
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.526
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.521
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.517
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.508
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.508
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.502
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.496
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.468
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.459
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.457
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.446
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.443
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.436
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.423
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.423
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.417
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.412
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.405
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.397
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.396
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.389
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.382
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.380
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.377
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.377
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.376
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.373
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.367
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.366
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.362
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.357
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.356
|
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.352
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.349
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.346
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.344
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.341
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.338
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.337
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.335
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.334
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.330
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.330
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.324
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.313
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.309
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.308
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.304
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.303
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.298
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.292
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.290
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.287
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.284
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.283
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.282
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.280
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.278
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.278
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.274
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.273
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.273
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.271
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.264
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.264
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.263
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.260
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.259
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.255
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.253
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.253
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.252
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.246
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.244
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.240
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.232
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.231
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.230
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.225
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.224
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.221
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.215
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.214
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.213
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.212
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.211
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.209
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.208
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.207
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.203
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.203
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.197
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.195
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.193
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.192
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.192
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.192
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.189
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.179
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.175
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.175
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.174
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.174
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.174
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.172
|
|
|
|
negative regulation of cartilage development
|
GO:0061037 |
17 |
0.170
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.169
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.169
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.168
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.165
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.164
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.163
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.159
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.159
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.158
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.155
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.155
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.155
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.154
|
|
|
|
sequestering of bmp in extracellular matrix
|
GO:0035582 |
3 |
0.153
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.151
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.151
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.150
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.148
|
|
|
|
regulation of response to reactive oxygen species
|
GO:1901031 |
9 |
0.148
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.144
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.143
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.142
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.140
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.140
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.140
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.139
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.138
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.138
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.136
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.135
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.134
|
|
|
|
phospholipase c activating angiotensin activated signaling pathway
|
GO:0086097 |
1 |
0.133
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.132
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.132
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.132
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.131
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.131
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.130
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.129
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.129
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.129
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.127
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.127
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.127
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.127
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.127
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.126
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.126
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.125
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902219 |
1 |
0.125
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.125
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.123
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.123
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.121
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.121
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.120
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.119
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.118
|
|
|
|
face development
|
GO:0060324 |
38 |
0.117
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.117
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.117
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.116
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.115
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.115
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.112
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.112
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.110
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.109
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.106
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.106
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.105
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.104
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.104
|
|
|
|
positive regulation of interferon gamma secretion
|
GO:1902715 |
3 |
0.104
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.104
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.103
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.103
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.102
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.102
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.102
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.099
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.099
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.098
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.097
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.097
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.096
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.096
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.095
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.094
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.094
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.093
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.093
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.092
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.091
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.091
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.090
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.090
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.090
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.090
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.088
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.088
|
|
|
|
negative regulation of chondrocyte differentiation
|
GO:0032331 |
13 |
0.087
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.086
|
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
14 |
0.085
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.085
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.084
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.083
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.082
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.082
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.082
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.082
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.081
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.081
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.081
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.081
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.080
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.080
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.080
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.079
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.079
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.078
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.078
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.077
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.077
|
|
|
|
positive regulation of fibronectin dependent thymocyte migration
|
GO:2000415 |
1 |
0.075
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.075
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.074
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.074
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.074
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.074
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.073
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.073
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.073
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.073
|
|
|
|
positive regulation of nitric oxide synthase activity
|
GO:0051000 |
2 |
0.072
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.071
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.071
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.070
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.070
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.069
|
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
4 |
0.068
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.068
|
|
|
|
cell aggregation
|
GO:0098743 |
18 |
0.068
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.067
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.066
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.066
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.064
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.064
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.063
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.063
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.063
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.063
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.063
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.063
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.063
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.063
|
|
|
|
negative regulation of heart rate
|
GO:0010459 |
4 |
0.062
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.061
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.061
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.061
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.061
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.061
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.061
|
|
|
|
aorta development
|
GO:0035904 |
23 |
0.061
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.060
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.060
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.060
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.060
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.060
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.059
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.059
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.059
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.059
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.059
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.059
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.059
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.059
|
|
|
|
negative regulation of smooth muscle cell apoptotic process
|
GO:0034392 |
1 |
0.059
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.058
|
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.058
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.058
|
|
|
|
regulation of transmission of nerve impulse
|
GO:0051969 |
1 |
0.057
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.057
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.057
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.057
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.057
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.056
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.056
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.056
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.056
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.056
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.055
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.055
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.055
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.054
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.053
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.053
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.053
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.053
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.053
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.052
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902218 |
1 |
0.052
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.052
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.052
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.052
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.052
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.051
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.051
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.051
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.051
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.050
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.050
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.050
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902239 |
1 |
0.049
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.049
|
|
|
|
positive regulation of adiponectin secretion
|
GO:0070165 |
1 |
0.049
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.048
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
22 |
0.048
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.048
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1990127 |
1 |
0.048
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.048
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.048
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.048
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.047
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.046
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.046
|
|
|
|
positive regulation of bone resorption
|
GO:0045780 |
13 |
0.046
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.046
|
|
|
|
regulation of metalloenzyme activity
|
GO:0048552 |
4 |
0.046
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.045
|
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.045
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.045
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.045
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.045
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.044
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.044
|
|
|
|
positive regulation of ras protein signal transduction
|
GO:0046579 |
13 |
0.044
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.044
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.044
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.044
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.044
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.044
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.044
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.043
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.043
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.043
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.043
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.043
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.043
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.043
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.043
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.042
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.042
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.042
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.041
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.041
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.041
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.041
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.041
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.041
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.040
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.040
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.040
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.040
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.040
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.040
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.040
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.039
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.039
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
23 |
0.039
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.038
|
|
|
|
detection of mechanical stimulus involved in equilibrioception
|
GO:0050973 |
2 |
0.038
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.038
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.038
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.038
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.038
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.038
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.037
|
|
|
|
cell communication by electrical coupling
|
GO:0010644 |
4 |
0.037
|
|
|
|
regulation of cell growth involved in cardiac muscle cell development
|
GO:0061050 |
3 |
0.037
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.037
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.037
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.037
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.036
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.036
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.036
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.036
|
|
|
|
negative regulation of neuron migration
|
GO:2001223 |
6 |
0.036
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.036
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.036
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.035
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.035
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.035
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.035
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.034
|
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.034
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.034
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.034
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.033
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.033
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.033
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.033
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.033
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.033
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.032
|
|
|
|
glomerular epithelial cell differentiation
|
GO:0072311 |
10 |
0.032
|
|
|
|
lymphocyte migration
|
GO:0072676 |
26 |
0.032
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.032
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.032
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.032
|
|
|
|
regulation of adiponectin secretion
|
GO:0070163 |
2 |
0.032
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.032
|
|
|
|
phasic smooth muscle contraction
|
GO:0014821 |
8 |
0.031
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.031
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.031
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.031
|
|
|
|
ventricular trabecula myocardium morphogenesis
|
GO:0003222 |
11 |
0.031
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.031
|
|
|
|
sequestering of extracellular ligand from receptor
|
GO:0035581 |
6 |
0.030
|
|
|
|
prevention of polyspermy
|
GO:0060468 |
4 |
0.030
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.030
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.030
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.030
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.030
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.030
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.030
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.030
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.029
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.029
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.029
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.029
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.029
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.029
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.029
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.028
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.028
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.028
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.028
|
|